Oxymetazoline (Rhofade)

SELF ADMINISTRATION - TOPICAL

Indications for Prior Authorization:

  • Treatment of persistent facial erythema associated with rosacea in adults

Patients must meet the following criteria for the indication(s) above:

  • Persistent facial erythema due to rosacea

  • 18 years of age or older
  • If the patient also has papulopustular lesions, the preferred agent is topical metronidazole
  • Patient has tried and failed Mirvaso
  • Warning/precautions in patients with CV disease, orthostatic hypotension, and/or uncontrolled hypertension/hypotension; risk of potentiation of vascular insufficiency; increased risk of angle closure glaucoma in patients with narrow-angle glaucoma

Dosing:

  • Apply a pea-sized amount once daily as a thin layer to the entire face (forehead, nose, cheeks, chin), avoiding the eyes and lips

Approval:

  • 1 year

Last review date: May 1, 2017

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar